(HealthDay)—A plan to let Medicare patients receive rebates that drug companies currently pay to insurers and middlemen has been withdrawn by the Trump administration.
Jul 12, 2019
0
0
Every American hospital has two front doors: The real one, and an imaginary revolving door.
Jul 1, 2019
0
0
Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, ...
Jun 21, 2019
0
0
As the Medicare system seeks to improve the care of older adults while also keeping costs from growing too fast, a new University of Michigan study suggests that one major effort may not be having as much of an impact as ...
Jun 19, 2019
0
5
Using Medicare data, new findings from The University of Texas Medical Branch at Galveston show for the first time that the rates of long term opiate therapy—a 90-day or more supply of opioids per year—for older cancer ...
May 14, 2019
0
0
Private insurers covering people receiving treatment for dialysis paid four times more than government insurance programs such as Medicare paid for the same service. The study found that government programs paid, on average, ...
May 14, 2019
0
0
A new study from the Johns Hopkins Bloomberg School of Public Health analyzed providers excluded from Medicare for fraud and abuse, and found that the patients they treated prior to being banned were more likely to be minorities, ...
May 7, 2019
1
1
Elderly survivors of breast cancer, lung cancer, and melanoma face risk of brain metastasis later in life, and may require extra surveillance in the years following initial cancer treatment.
May 3, 2019
0
7
When Kira Ryskina works in Penn Presbyterian Medical Center, she usually sees her patients every day.
Apr 3, 2019
0
3
A groundbreaking new study holds heartening news for older Americans.
Mar 15, 2019
0
421
